pharmaceutical investing CMS Grants Progenics New Technology Add-On Payment for Inpatient Use of AZEDRA
pharmaceutical investing Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy
pharmaceutical investing Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration
pharmaceutical investing Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
pharmaceutical investing Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer
VanadiumCorp Completes Rock Chip Sampling Program at its Lac Doré Vanadium-Iron-Titanium Project; 53 Samples Submitted to AGAT Laboratories for Analysis
QIMC Launches 78-Kilometre 2D Seismic Campaign Across Quebec and Nova Scotia Natural Hydrogen Districts
Brixton Metals Reports Consistent Silver Grades Across All 85 Holes from Maiden Tailings Drill Program at the Langis Silver Project
